Objective Gastric cancer is one of the most common malignant tumor.At present,gastrectomy with D1/D2 lymphadenectomy is standard treatment for resectable advanced gastric cancer.However,in early gastr
Objective Gastric cancer(GAC) is the fifth most prevalent tumor in the world and also is the third leading cause of cancer-related death.The invasion and metastasis of GAC is a multi-step process and
Objective Although apatinib,immune checkpoint inhibitors,and trifluridine/tipiracil have shown promising results in phase Ⅲ randomized controlled trials(RCTs),there is no head-to-head comparison among